SQZ Biotechnologies Co

NYSE:SQZ  
12.17
-0.07 (-0.57%)
Earnings Announcements

SQZ Biotechnologies Reports 2020 Financial Results

Published: 03/18/2021 11:02 GMT
SQZ Biotechnologies Co (SQZ) - Sqz Biotechnologies - Believes Cash, Equivalents As of Dec 31, 2020, to Be Sufficient to Fund Operating, Capex Needs Through H1 of 2023.
Revenue is expected to be $8.57 Million
Adjusted EPS is expected to be -$0.56

Next Quarter Revenue Guidance is expected to be $6.37 Million
Next Quarter EPS Guidance is expected to be -$0.71

More details on our Analysts Page.